Type 1 diabetes. From biomarkers to prevention

被引：2
|
作者：
Boitard, Christian [1 ]
机构：
[1] Hop Cochin, Serv Diabetol, 123 Blvd Port Royal, F-75014 Paris, France
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2017年 / 201卷 / 1-3期
关键词：
DIABETES MELLITUS; TYPE I; AUTOANTIBODIES; AUTOIMMUNITY; ENVIRONMENT; IMMUNOTHERAPY; NOD MICE; ISLET AUTOANTIBODIES; RISK-FACTORS; BETA-CELLS; PROGRESSION; GENETICS; HUMANS; SYSTEM;
D O I：
10.1016/S0001-4079(19)30527-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 1 diabetes is an auto-immune disease that leads to the destruction of insulin-secreting cells by the immune system. The auto-immune response to insulin-secreting cells, from the expansion of autoreactive lymphocytes to the activation of effectors involved in the destruction of insulin-secreting cells, has been extensively defined in preclinical models of type 1 diabetes. However, underlying mechanisms initiating the autoimmune process remain ill-defined. The type I diabetes challenge is in relating immune mechanisms involved with new therapeutic strategies that will lead to disease prevention. The identification of new biomarkers is a prerequisite for progress towards preventive strategies.
引用
收藏
页码：297 / 307
页数：11
相关论文
共 50 条
  • [1] Type 1 diabetes. From biomarkers to its prevention DISCUSSION
    Komajda, Michel
    Wemeau, Jean-Louis
    Henrion, M. Roger
    Sraer, M. Jean-Daniel
    Brissot, M. Pierre
    Dufier, M. Jean-Louis
    Bouchard, M. Philippe
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2017, 201 (1-3): : 307 - 310
  • [2] Prediction and prevention of type 1 diabetes.
    Morales A.E.
    She J.X.
    Schatz D.A.
    Current Diabetes Reports, 2001, 1 (1) : 28 - 32
  • [3] BEZAFIBRATE FOR THE PREVENTION OF TYPE II DIABETES.
    Flory, J. H.
    Ellenberg, S.
    Strom, B. L.
    Hennessy, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S16 - S16
  • [4] Serum exocrine enzymes as biomarkers of response to immunotherapy in type 1 diabetes.
    Bruggeman, Brittany
    McGrail, Kieran
    Gonzalez, Nicole
    Wasserfall, Clive
    Campbell-Thompson, Martha
    Atkinson, Mark
    Haller, Michael
    Schatz, Desmond
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 58 - 59
  • [5] A case of type 1 diabetes.
    Ambard, L
    Lux, H
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1921, 84 : 955 - 957
  • [6] Fulminant Type 1 Diabetes in Korean Children with Type 1 Diabetes.
    Kim, M. S.
    Kim, C. J.
    Ko, C. W.
    Lee, D. Y.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [7] Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review
    Verier-Mine, O.
    DIABETES & METABOLISM, 2010, 36 (06) : 595 - 616
  • [8] Genetics of Type 1A Diabetes.
    Sepe, Vincenzo
    Loviselli, Andrea
    Bottazzo, Gian Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02): : 211 - 211
  • [9] β-KLOTHO IN PATIENTS WITH TYPE 1 DIABETES.
    Iniguez, German
    Gaete, Ximena
    Miranda, Lia
    Lopez, Patricia
    Mira, Magdalena
    Codner, Ethel
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 606 - 606
  • [10] Type 1 diabetes. Topics 2011
    Siegmund, T.
    DIABETOLOGE, 2012, 8 (05): : 377 - +
12345